Compare FBIO & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBIO | ANTA |
|---|---|---|
| Founded | 2006 | 2022 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.4M | 68.2M |
| IPO Year | 2011 | 2024 |
| Metric | FBIO | ANTA |
|---|---|---|
| Price | $2.00 | $1.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.25 |
| AVG Volume (30 Days) | ★ 261.5K | 45.6K |
| Earning Date | 11-13-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.40 | N/A |
| EPS | ★ 2.86 | N/A |
| Revenue | ★ $63,262,000.00 | N/A |
| Revenue This Year | $24.55 | N/A |
| Revenue Next Year | $43.73 | $38.46 |
| P/E Ratio | ★ $0.68 | $19.77 |
| Revenue Growth | ★ 9.69 | N/A |
| 52 Week Low | $1.83 | $1.69 |
| 52 Week High | $4.53 | $12.44 |
| Indicator | FBIO | ANTA |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 27.08 |
| Support Level | N/A | N/A |
| Resistance Level | $2.17 | $4.19 |
| Average True Range (ATR) | 0.08 | 0.28 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 44.12 | 12.99 |
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Antalpha Platform Holding Co provides financing, technology and risk management solutions to institutional and corporate customers in the crypto asset industry. The company operates through Antalpha Prime platform in the following areas: Supply chain financing and Technology and services. Its revenue prominently consists of technology financing fees charged on the supply chain loans.